Biotech stocks are risky, volatile, and potentially worth a fortune. But are they biblically sound?

Some evangelical investors are betting Christian-friendly stocks can outperform the market, and they’re leaning heavily on biotech to prove them right.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • They had me until the end of the story when they demonized the LGBT community. Oh well.

  • Biblically responsible? Can someone suggest a fund I can invest in that specifically excludes these whack-jobs?

  • ‘“That’s what we call inspiring transformation,” Netzly said.’

    Since scientists are overwhelmingly non-religious, imposing religion on biotechs will inspire an exodus or two and “Inspire” will be radioactive.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy